Dirlotapide
685 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
685
Total Reports
20
Deaths Reported
290.0%
Death Rate
Active Ingredients
Dirlotapide
Administration Routes
OralUnknownTopicalOphthalmic
Species Affected
Dog 602
Unknown 76
Human 7
Most Affected Breeds
Unknown 83
Crossbred Canine/dog 76
Retriever - Labrador 73
Dachshund (unspecified) 43
Retriever - Golden 37
Chihuahua 32
Beagle 31
Dog (unknown) 23
Pug 19
Sheepdog - Shetland 17
Most Reported Reactions
Vomiting 173
Hyperextension 123
INEFFECTIVE, WEIGHT LOSS 123
Anorexia 105
Depression 81
INEFFECTIVE, APPETITE SUPPRESSION 76
Diarrhoea 60
Weight gain 50
Vials, Leaking 49
Elevated alanine aminotransferase (ALT) 37
Elevated serum alkaline phosphatase (SAP) 37
Uncoded sign 28
Outcome Breakdown
Ongoing
66 (55.9%)
Recovered/Normal
20 (16.9%)
Died
19 (16.1%)
Outcome Unknown
12 (10.2%)
Euthanized
1 (0.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.